Search

Your search keyword '"Corley, Douglas A."' showing total 54 results

Search Constraints

Start Over You searched for: Author "Corley, Douglas A." Remove constraint Author: "Corley, Douglas A." Publisher american association for cancer research (aacr) Remove constraint Publisher: american association for cancer research (aacr)
54 results on '"Corley, Douglas A."'

Search Results

1. Table S1 from Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds

2. Table S1 from Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds

3. Table S2 from Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds

4. Table S2 from Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds

5. Data from Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds

6. Data from Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds

7. Supplementary Figure 1 from Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds

8. Supplementary Figure 1 from Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds

9. Data from Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds

10. Supplementary Figure 1 from Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds

11. Table S2 from Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds

12. Table S1 from Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds

13. Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds

14. Table S1 from Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds

15. Supplementary Figure 1 from Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds

16. Table S2 from Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds

17. Supplementary Figure 2 from Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems

18. Data from Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems

19. Supplementary Figure 1 from Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems

20. Supplementary Data from Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems

21. Data from Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems

22. Supplementary Figure 3 from Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems

23. Supplementary Data from Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems

24. Supplementary Figure 3 from Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems

25. Supplementary Figure 2 from Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems

26. Supplementary Figure 1 from Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems

27. Supplementary Tables S1-S2 from Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems

28. Supplementary Figure legends from A Newly Identified Susceptibility Locus near FOXP1 Modifies the Association of Gastroesophageal Reflux with Barrett's Esophagus

30. Supplementary figure 1 from A Newly Identified Susceptibility Locus near FOXP1 Modifies the Association of Gastroesophageal Reflux with Barrett's Esophagus

31. Data from Pleiotropic Analysis of Cancer Risk Loci on Esophageal Adenocarcinoma Risk

33. Supplementary Tables S1-S2 from Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems

34. Supplementary figure 1 from A Newly Identified Susceptibility Locus near FOXP1 Modifies the Association of Gastroesophageal Reflux with Barrett's Esophagus

35. Data from A Newly Identified Susceptibility Locus near FOXP1 Modifies the Association of Gastroesophageal Reflux with Barrett's Esophagus

36. Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort

37. Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old

38. Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval

39. eQTL Set–Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma

40. Abstract 1446: Genetic risk factors for the development of multiple primary cancers

41. Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda

42. Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems

43. Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems

44. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study

46. Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems

48. Pleiotropic Analysis of Cancer Risk Loci on Esophageal Adenocarcinoma Risk

49. A Newly Identified Susceptibility Locus nearFOXP1Modifies the Association of Gastroesophageal Reflux with Barrett's Esophagus

50. The Colorectal Cancer Screening Process in Community Settings: A Conceptual Model for the Population-Based Research Optimizing Screening through Personalized Regimens Consortium

Catalog

Books, media, physical & digital resources